China Junshi’s potential COVID-19 drug shows promise in small trial
An antiviral oral drug being co-developed by Shanghai Junshi Biosciences’ subsidiary and other
EU urged to review remdesivir supply deal after COVID-19 trial results
The European Union should renegotiate a R20 billion ($1.2 billion) contract it sealed last week with
What you need to know about the ARV that treats severe COVID-19
Pharmaceutical giant CIPLA has manufactured thousands of dosages of the anti-viral drug Remdesivir,
Remdesivir now available in SA for COVID-19 treatment
Drug manufacturer, CIPLA South Africa, has announced that Remdesivir, a medicine that could make a
US doctors call for Remdesivir data to guide coronavirus treatment
US doctors and others in the scientific community are calling for the release of data that convinced
Severely ill patients improve after Gilead drug: NEJM
More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment